SUPPORTING INFORMATION S1: DNA Nanotube Design
The DNA nanotubes reported here consist of six parallel double helices that are formed into a tube structure by combining the single-stranded M13mp18 DNA molecule with 170 staple strands using the DNA origami method of Rothemund. 25 As shown in Fig. S1(a) , the scaffold is arranged into six numbered helices with the ends of the M13mp18 located in the middle of helix 1. From the 5' end, the scaffold proceeds to the left with crossovers at the ends of the nanotube and two staggered crossovers near the middle. The nucleotide numbers for the crossovers are indicated in the figure. Staple strands are grouped into 86 columns and numbered from the left end, as shown in Fig. S1(b) . Staples are labeled according to the helix and column location of their 5' end. The first column of staples starts 14 nucleotides from the left end scaffold crossovers. Columns 11-13 show the 3 column repeating motif in which each staple consists of three 14 nucleotide domains complementary to a section of the M13mp18 scaffold and spans 3 helices. Although not used in the current study, three random 20 nucleotide stickyends, labeled A, B, and C, are added to staples in columns 4, 7, and 10 of helix 3. For each sticky-end, the helix 3 domain complementary to M13mp18 is lengthened by 7 nucleotides and the adjacent staple domain is correspondingly shortened, as illustrated in the figure.
The staple strand layout in the middle of the nanotube is shown in Fig. S1 (c). The 5' and 3' ends of the M13mp18 scaffold are located in helix 1 and staple column 43. Mid-nanotube scaffold crossovers are located in staple columns 39 and 41. The same A, B, and C sticky-ends are added to staples in columns 41, 45, and 48 of helix 3. Figure S1(d) illustrates the staple layout for the right end of the nanotube. A, B, and C sticky-ends are added to staples of columns 77, 80, and 83 of helix 3. Four nucleotides remain unhybridized at the end of each helix. A schematic of the formed DNA nanotube with A, B, and C sticky-ends is shown in Fig. S1 (e). The M13mp18 scaffold begins and ends in helix 1, column 43. Scaffold crossovers are located at the ends and in columns 39 and 41. A,B, and C sticky-ends are added to staples 41, 45, and 48 of helix 3.
(d) Staple layout for the right end of the tube. Sticky-ends are added to staples in helix 3 in columns 77, 80, and 83. Four nucleotides remain at the end of each helix. (e) Schematic of the formed tube illustrating the A, B, and C sticky-ends along helix 3 of the formed nanotube.
SUPPORTING INFORMATION S2: DNA Nanotube Staple Strands
To facilitate generation of the staple strands required to form a 6-helix DNA nanotube, a Perl script was written to layout the scaffold sequence into the geometric raster pattern according to a given set of turning points. The script accepts the M13mp18 sequence as an input, divides the sequence into regions demarcated by turning points, and then outputs the scaffold and its complement according to the designed pattern. The complementary sequence is then easily divided into staple strands according to the desired motif. # discard everything that isn't a G, A, T, or C my $dnaSequence = join '', @seqLines;
# concatenate the lines into one big string print 'dnaSequence has ' . length($dnaSequence) . " bases.\n"; # The scaffold structure is described as a set of lines and turnaround points. # Data structure: arefSubsequenceLines -> arefSubsequenceRanges -> [startPos, endPos] my $arefSubsequenceLines = [ [ [ 595, 1] , [7249, 6637] ], [ [ 596, 1162] , [5996, 6636] ], [ [1729, 1163] , [5995, 5355] ], [ [1730, 2268] , [4686, 5354] ], [ [2807, 2269] , [4685, 4017] ], [ [2808, 4016], ], ];
# Use the position data to divide the DNA sequence into the # base pair sequences that make up each line of the structure. my @designLines; foreach my $arefSubsequenceRanges (@$arefSubsequenceLines) { my $designLine = ""; foreach my $arefSubsequenceRange (@$arefSubsequenceRanges) { my ($p1, $p2) = @$arefSubsequenceRange;i8i8sx print "p1=$p1, p2=$p2; "; if ($p1 <= $p2) { # don't need to reverse the subsequence? # (i.e., should appear left to right?) $designLine .= "*" if length($designLine) && $p1 != 1; # separate subsequences # with an asterisk $designLine .= substr $dnaSequence, $p1-1, $p2-$p1+1; } else { # must reverse the subsequence because it must # appear right to left $designLine .= "*" if length($designLine) && $p2 != 1; # separate subsequences # with an asterisk $designLine .= reverse substr $dnaSequence, $p2-1, $p1-$p2+1; } print "length(designLine)=" . length($designLine) . "\n"; } push @designLines, $designLine; print "\n"; } Table S1 provides the name and sequence for the 170 unique staple strands used for the 6-helix DNA nanotube reported here. The names are derived from the helix and column location of the 5' end of the staple strand, as described in S1. There are 152 strands with 42 nucleotides consisting of 3 domains each 14 nucleotides in length. Nine strands are 69 nucleotides in length, consisting of a helix-3 domain lengthened by 7 nucleotides plus a random 20 nucleotide sticky-end sequence. Nine strands adjacent to the lengthened staples are shortened by 7 nucleotides leaving 35 nucleotides. 
SUPPORTING INFORMATION S3: Modified Staple Strands
To form functionalized DNA nanotubes with 29 attachment sites for streptavidin-conjugated nanoparticles, all 29 staple strands of helix 4 (H4-C1 to H4-C85) were modified by adding a 5 thymine tether to the 3' end followed by a biotin molecule. During synthesis of the nanotubes, these strands were substituted for the corresponding unmodified staple strands. Note that the strands are labeled in helix 4
by the location of their 5' end, but the biotin modified 3' ends are located in helix 6. To synthesize nanotubes with 15, 9 and 5 available binding sites, the subsets of the helix 4 staple strands were substituted. The column numbers of the substituted staple strands are listed below.
For 15 binding sites, every other staple of helix 4 was substituted: 1, 7, 13, 19, 25, 31, 37, 43, 49, 55, 61, 67, 73, 79, 85 .
For 9 binding sites, every third staple of helix 4 was substituted, starting with column 7: 7, 16, 25, 34, 43, 52, 61, 70, 79.
For 5 binding sites, every fifth staple of helix 4 was substituted, starting with column 5: 13, 28, 43, 58, 73.
SUPPORTING INFORMATION S4: AFM Calibration
To validate the linearity, stability, and accuracy of the piezoelectric scanners, the AFM was calibrated using: 1) a surface topography reference (STR3-1800P, VLSI Standards), and 2) the atomic step height of freshly cleaved, ZYH grade, highly ordered pyrolytic graphite (HOPG, Veeco Metrology). The STR was lithographically fabricated onto a silicon dioxide on silicon die (Model # STR3-1800P) and
contained an array of alternating silicon dioxide bars. With a pitch distance of 3 µm in both the X and Y directions, the bars formed 180 nm deep rectangular pits. Following Veeco Metrology guidelines, the AFM Z-axis piezoelectric stack was calibrated for neutral (0 V ± 5 V), extended (50 V ± 5 V), and retracted (-50 V ± 5 V) conditions. As shown in Table S2 , a mean step height of 180.4 ± 0.4 nm was measured at 0 V ± 5 V and is well within the 1-2% accuracy specified by the manufacturer. To verify the calibration of the AFM at small length scales, the mean atomic step height of freshly cleaved, ZYH grade, HOPG was measured to be 0.35 nm with a standard deviation of 0.01 nm. Both the tabulated data and an example height image of the graphite step height are shown in Table S3 and Figure S2 
SUPPORTING INFORMATION S5: AFM Height Profiles
According to X-ray analysis, dehydrated streptavidin crystals are 4.6 nm thick. [48] [49] [50] [51] Within this study, the mean height of free streptavidin dispersed onto freshly-cleaved mica was measured under various imaging conditions. In Fig. S3 , the AFM free air drive amplitude and setpoint were modulated between 0.5 V (setpoint = 0.35V) and 2 V (setpoint = 1.75V) for a similar scan area.
During sequential images under these conditions, the mean height for 10 streptavidin molecules alternated between (a) 1.3 ± 0.3 nm, (b) 0.5 ± 0.2 nm, and (c) 1.3 ± 0.3 nm, respectively. Elastic recovery of the mean streptavidin height indicates the lack of significant sample degradation. nanotubes, (e-h) free streptavidin, and (i-l) free streptavidin-conjugated quantum dots on mica. Images of the same sample area were obtained with free air drive amplitudes of 0.5 V and 2 V using setpoints at ~90% and ~50% of the free air drive amplitude, as shown in the traces provided above each image. The mean heights of the features are provided in each AFM height image.
SUPPORTING INFORMATION S6: AFM Axial Profiles
Axial profiles of DNA nanotubes were obtained using a box profile tool that averages height data perpendicular to the box axis. This method provides smoother height features, but absolute height information is lost by averaging. Figure S5 illustrates use of the box profile tool along the axis of functionalized DNA nanotubes with 9 available biotin binding sites. The nanotube measured in Fig.   S5 (a) shows 9 attached streptavidin molecules and the nanotube in Fig. S5(c) Images of the sample were acquired at 120 keV. The image shown in Fig. S7 reveals an array of 15 quantum dots formed along the length of a DNA nanotube. The average spacing of the quantum dots was 28 ± 7 nm, which agrees with the average spacing measured by AFM for nanotubes with 29 binding sites.
FIGURE S7
. TEM image of a 15 quantum dot array formed by successful attachment to a DNA nanotube functionalized with 29 biotin binding sites. The average quantum dot spacing was 28 ± 7 nm, which agrees with the average spacing measured by AFM. The DNA nanotube was not stained, and the image was acquired at 120 keV.
SUPPORTING INFORMATION S8: Center-to-Center Separation of Streptavidin-Conjugated QDs
For each design periodicity, AFM images of DNA nanotubes with attached quantum dots were analyzed to measure the center-to-center separation distances between nearest-neighbor quantum dots.
Histograms of the measured separations are shown in Fig. S8 . In each case, no quantum dots were observed with a center-to-center separation less than 20 nm. Thus, the data indicate that in solution, the effective diameter of the streptavidin-conjugated quantum dots is 20 nm, in agreement with the specifications provided by Invitrogen.
FIGURE S8
. Center-to-center distance between nearest-neighbor streptavidin-conjugated quantum dots attached to DNA origami nanotubes with (a) 5, (b) 9, (c) 15, and (d) 29 biotin binding sites.
SUPPORTING INFORMATION S9: Quantum Dot Counting Methodology
To generate histograms of the numbers of attached quantum dots per DNA nanotube, large area AFM images of DNA nanotubes with attached quantum dots were analyzed for each designed attachment periodicity. The example AFM images in Fig. S9(a-d) illustrates the methodology used in classifying a quantum dot as attached to a DNA nanotube. Regions in which multiple nanotubes contacted each other were excluded from statistical analysis (e.g., "X" region in Fig. S9(d) ). In Figs. S9(c) and (d) , counted quantum dots are indicated with a circled dot. Quantum dots that appeared close to but separated from a nanotube were not counted. illustrates excluded nanotubes. Counted quantum dots are marked with a circled dot.
SUPPORTING INFORMATION S10: Attachment of Pure Streptavidin
For the case of 5 available binding sites, AFM images of functionalized DNA nanotubes with attached pure streptavidin were analyzed to determine the number of attached molecules per nanotube. Figure   S10 (a) shows a histogram of the number of attached streptavidin molecules per DNA nanotube. For comparison, a histogram of the number of attached quantum dots is shown in Fig. S10(b) , also for 5 available binding sites. Although the attachment histogram of streptavidin is peaked for 5 attached molecules per DNA nanotube, the average attachment probability of 0.79 for pure streptavidin attachment was calculated from Equation 2 and is only slightly higher than for quantum dot attachment.
Thus, for the cases of large separations between attachment sites (no steric hindrance), the attachment probabilities for streptavidin and quantum dots may reflect missing or unavailable biotin sites.
FIGURE S10. Histogram (bars) and calculated binomial distributions (lines) for the number of attached (a) pure streptavidin, and (b) quantum dots for DNA nanotubes functionalized with 5 biotin binding sites. Data for each histogram were compiled from AFM image analysis for over 100 separate nanotubes, with the exact number, N, shown in each histogram. The average attachment probabilities used to generate the binomial distributions are indicated for each case.
SUPPORTING INFORMATION S11: Projected Nearest-Neighbor Quantum Dot Separations
For direct evidence of steric hindrance or site poisoning, AFM images were analyzed to determine nearest-neighbor separation distances projected along the axis of the DNA nanotubes. The AFM images shown in Fig. S11 illustrate the measurement process. To facilitate accurate measurements, long white guide lines are drawn through the center of the quantum dots and perpendicular to the nanotube tangent.
The projected separation is measured as the distance between the intersections of the guide lines and the nanotube axis tangents. For nanotubes with significant curvature between quantum dots, multiple axial measurements were combined, as illustrated in Fig. S11(d) . 
